Stomach
Amylase + lipase + protease
Digestive enzymes
Other names: Pangestyme
FAA guidance
Acceptable in the FAA document cited.
The FAA's MedGuide lists amylase + lipase + protease (Pangestyme) as allowed, for supplement, with no wait after the first dose, after later doses or after the final dose, used per label directions.
Track your medicationsMore detail: amylase + lipase + proteaseThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
Show the FAA's words: amylase + lipase + proteaseThe official FAA wording: three passages, each with its document and dateOpen
Generic: amylase + lipase + protease
Brand Name: Pangestyme
Drug Class: Digestive enzymes
Underlying Condition: Supplement
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.